Abstract
Biomedical research with human subjects has expanded outside of traditional medical centers and hospitals into other health care entities, such as rehabilitation facilities, free-standing out-patient treatment centers, and even home-health agencies. Regardless of the location, federal regulations mandate that all human-subjects research must be overseen by an institutional review board (IRB) or ethics committee to ensure the research abides by the Code of Federal Regulations. Consequently, all human-subjects research must be reviewed and approved by an IRB prior to initiation of any research procedures. Unfortunately, many of these nontraditional research facilities do not have easy access to an IRB. This does not render such research exempt from federal oversight. Clinicians at these facilities have viable options for obtaining IRB approval and legally conducting such research. This paper outlines the available options and their pros and cons.
Footnotes
- Correspondence: Todd W Rice MD MSc, Division of Allergy, Pulmonary, and Critical Care Medicine, T-1218 MCN and the Vanderbilt Institutional Review Board, Vanderbilt University School of Medicine, Nashville TN 37232-2650. Email: todd.rice{at}vanderbilt.edu.
Dr Rice presented a version of this paper at the RESPIRATORY CARE Journal Symposium at the 53rd International Respiratory Congress of the American Association for Respiratory Care, held December 1-4, 2007, in Orlando, Florida.
The author reports no conflict of interest related to the content of this paper.
- Copyright © 2008 by Daedalus Enterprises Inc.